In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, outlines the role digital supply chain tools and analytics ...

Hospitals are rationing cancer treatments. Pharmacies are scrambling to fill routine antibiotic prescriptions. And across the USA, patients are facing growing delays, substitutions, or outright ...

The more than $36 million center is hoped to be a “buffer” against supply chain disruptions and improve oversight, said a St.

A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.

Over the past 90 years, at least 25 documented incidents of ingesting medicines contaminated with high levels of toxic ...

With tariffs looming and pricing policies shifting, life sciences companies may be on the cusp of “pivotal moment,” according ...

The deal, which eliminates tariffs on most finished pharmaceutical products and medical devices, is expected to boost India’s ...

The India-UK trade agreement heralds significant developments in the pharmaceutical sector, fostering collaboration in drug imports and research. The deal boosts economic ties, strengthens supply ...

US pharma tariffs may start low and rise, risking drug shortages, higher costs, and pressure on generics amid reshoring push.

Drug shortages have surged, highlighting the need for a resilient pharmaceutical supply chain. Onshoring and AI are key to ...

The World Health Organization said on Thursday systemic weaknesses in the oversight of the global pharmaceutical supply chain ...